These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 8760298)
1. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Loughran O; Malliri A; Owens D; Gallimore PH; Stanley MA; Ozanne B; Frame MC; Parkinson EK Oncogene; 1996 Aug; 13(3):561-8. PubMed ID: 8760298 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Loughran O; Clark LJ; Bond J; Baker A; Berry IJ; Edington KG; Ly IS; Simmons R; Haw R; Black DM; Newbold RF; Parkinson EK Oncogene; 1997 Apr; 14(16):1955-64. PubMed ID: 9150362 [TBL] [Abstract][Full Text] [Related]
4. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
5. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
7. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Munro J; Stott FJ; Vousden KH; Peters G; Parkinson EK Cancer Res; 1999 Jun; 59(11):2516-21. PubMed ID: 10363964 [TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
9. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827 [TBL] [Abstract][Full Text] [Related]
10. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438 [TBL] [Abstract][Full Text] [Related]
11. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Herman JG; Jen J; Merlo A; Baylin SB Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003 [TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of murine p16INK4a and p15INK4b genes. Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726 [TBL] [Abstract][Full Text] [Related]
14. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
15. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Reznikoff CA; Yeager TR; Belair CD; Savelieva E; Puthenveettil JA; Stadler WM Cancer Res; 1996 Jul; 56(13):2886-90. PubMed ID: 8674033 [TBL] [Abstract][Full Text] [Related]
16. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas. Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133 [TBL] [Abstract][Full Text] [Related]
17. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors. Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215 [TBL] [Abstract][Full Text] [Related]
18. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195 [TBL] [Abstract][Full Text] [Related]
20. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]